nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—OPRM1—nicotine dependence	0.881	1	CbGaD
Naloxone—TLR4—brain—nicotine dependence	0.00386	0.165	CbGeAlD
Naloxone—CREB1—cardiovascular system—nicotine dependence	0.00346	0.148	CbGeAlD
Naloxone—Rhinorrhoea—Varenicline—nicotine dependence	0.00297	0.0935	CcSEcCtD
Naloxone—CREB1—midbrain—nicotine dependence	0.0027	0.116	CbGeAlD
Naloxone—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00261	0.0493	CbGpPWpGaD
Naloxone—Levallorphan—OPRM1—nicotine dependence	0.00237	0.219	CrCbGaD
Naloxone—Hot flush—Varenicline—nicotine dependence	0.00187	0.0588	CcSEcCtD
Naloxone—Menopausal symptoms—Varenicline—nicotine dependence	0.00185	0.0583	CcSEcCtD
Naloxone—CREB1—brain—nicotine dependence	0.0017	0.0727	CbGeAlD
Naloxone—Irritability—Varenicline—nicotine dependence	0.00167	0.0525	CcSEcCtD
Naloxone—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00162	0.0306	CbGpPWpGaD
Naloxone—Nasopharyngitis—Varenicline—nicotine dependence	0.00156	0.0492	CcSEcCtD
Naloxone—OPRM1—midbrain—nicotine dependence	0.00146	0.0624	CbGeAlD
Naloxone—ESR1—cardiovascular system—nicotine dependence	0.00136	0.0583	CbGeAlD
Naloxone—Methylnaltrexone—OPRM1—nicotine dependence	0.00136	0.126	CrCbGaD
Naloxone—OPRD1—brain—nicotine dependence	0.00134	0.0575	CbGeAlD
Naloxone—Depression—Varenicline—nicotine dependence	0.00134	0.0422	CcSEcCtD
Naloxone—CREB1—Hypothetical Network for Drug Addiction—DRD2—nicotine dependence	0.00132	0.025	CbGpPWpGaD
Naloxone—OPRK1—brain—nicotine dependence	0.00129	0.0551	CbGeAlD
Naloxone—SLCO1A2—midbrain—nicotine dependence	0.00125	0.0537	CbGeAlD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB3—nicotine dependence	0.00125	0.0237	CbGpPWpGaD
Naloxone—Nalbuphine—OPRM1—nicotine dependence	0.00125	0.115	CrCbGaD
Naloxone—Hallucination—Varenicline—nicotine dependence	0.0012	0.0378	CcSEcCtD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA6—nicotine dependence	0.00119	0.0224	CbGpPWpGaD
Naloxone—Cardiac disorder—Varenicline—nicotine dependence	0.00112	0.0353	CcSEcCtD
Naloxone—Angiopathy—Varenicline—nicotine dependence	0.0011	0.0345	CcSEcCtD
Naloxone—Mediastinal disorder—Varenicline—nicotine dependence	0.00109	0.0343	CcSEcCtD
Naloxone—Chills—Varenicline—nicotine dependence	0.00108	0.0341	CcSEcCtD
Naloxone—Mental disorder—Varenicline—nicotine dependence	0.00106	0.0333	CcSEcCtD
Naloxone—Oxymorphone—OPRM1—nicotine dependence	0.00101	0.0939	CrCbGaD
Naloxone—Naltrexone—OPRM1—nicotine dependence	0.00101	0.0939	CrCbGaD
Naloxone—Tremor—Varenicline—nicotine dependence	0.000985	0.031	CcSEcCtD
Naloxone—Agitation—Varenicline—nicotine dependence	0.000966	0.0304	CcSEcCtD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00094	0.0178	CbGpPWpGaD
Naloxone—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000931	0.0176	CbGpPWpGaD
Naloxone—OPRM1—brain—nicotine dependence	0.000915	0.0392	CbGeAlD
Naloxone—Convulsion—Varenicline—nicotine dependence	0.000911	0.0287	CcSEcCtD
Naloxone—Hypertension—Varenicline—nicotine dependence	0.000908	0.0286	CcSEcCtD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000891	0.0169	CbGpPWpGaD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000889	0.028	CcSEcCtD
Naloxone—Hydrocodone—OPRM1—nicotine dependence	0.000887	0.0821	CrCbGaD
Naloxone—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000876	0.0166	CbGpPWpGaD
Naloxone—CREB1—Opioid Signalling—OPRM1—nicotine dependence	0.000869	0.0164	CbGpPWpGaD
Naloxone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000868	0.0164	CbGpPWpGaD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA4—nicotine dependence	0.000857	0.0162	CbGpPWpGaD
Naloxone—Nervous system disorder—Varenicline—nicotine dependence	0.000841	0.0265	CcSEcCtD
Naloxone—Tachycardia—Varenicline—nicotine dependence	0.000837	0.0264	CcSEcCtD
Naloxone—Skin disorder—Varenicline—nicotine dependence	0.000833	0.0262	CcSEcCtD
Naloxone—Hyperhidrosis—Varenicline—nicotine dependence	0.000829	0.0261	CcSEcCtD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB4—nicotine dependence	0.000822	0.0155	CbGpPWpGaD
Naloxone—CREB1—ErbB1 downstream signaling—WASF2—nicotine dependence	0.000818	0.0155	CbGpPWpGaD
Naloxone—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000816	0.0154	CbGpPWpGaD
Naloxone—Oxycodone—OPRM1—nicotine dependence	0.00081	0.0749	CrCbGaD
Naloxone—CREB1—TCR Signaling Pathway—OPRM1—nicotine dependence	0.000798	0.0151	CbGpPWpGaD
Naloxone—SLCO1A2—brain—nicotine dependence	0.000788	0.0337	CbGeAlD
Naloxone—ALB—brain—nicotine dependence	0.000783	0.0336	CbGeAlD
Naloxone—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000768	0.0145	CbGpPWpGaD
Naloxone—Dyspnoea—Varenicline—nicotine dependence	0.000765	0.0241	CcSEcCtD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—nicotine dependence	0.000764	0.0144	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000754	0.0143	CbGpPWpGaD
Naloxone—Buprenorphine—OPRM1—nicotine dependence	0.000746	0.069	CrCbGaD
Naloxone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000741	0.0233	CcSEcCtD
Naloxone—Hydromorphone—OPRM1—nicotine dependence	0.000735	0.068	CrCbGaD
Naloxone—Pain—Varenicline—nicotine dependence	0.000734	0.0231	CcSEcCtD
Naloxone—CREB1—Neuronal System—CHRNB3—nicotine dependence	0.00072	0.0136	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—CHRNA6—nicotine dependence	0.000683	0.0129	CbGpPWpGaD
Naloxone—Abdominal pain—Varenicline—nicotine dependence	0.000678	0.0214	CcSEcCtD
Naloxone—Body temperature increased—Varenicline—nicotine dependence	0.000678	0.0214	CcSEcCtD
Naloxone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000672	0.0127	CbGpPWpGaD
Naloxone—ESR1—brain—nicotine dependence	0.000668	0.0286	CbGeAlD
Naloxone—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000663	0.0125	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000649	0.0123	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000644	0.0122	CbGpPWpGaD
Naloxone—Morphine—OPRM1—nicotine dependence	0.000625	0.0578	CrCbGaD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—nicotine dependence	0.000623	0.0118	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000618	0.0117	CbGpPWpGaD
Naloxone—Asthenia—Varenicline—nicotine dependence	0.000616	0.0194	CcSEcCtD
Naloxone—TLR4—Innate Immune System—WASF2—nicotine dependence	0.000599	0.0113	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—FGD1—nicotine dependence	0.000589	0.0111	CbGpPWpGaD
Naloxone—Diarrhoea—Varenicline—nicotine dependence	0.000587	0.0185	CcSEcCtD
Naloxone—TLR4—Innate Immune System—WASF1—nicotine dependence	0.000575	0.0109	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000574	0.0109	CbGpPWpGaD
Naloxone—CYP2C8—brain—nicotine dependence	0.00055	0.0236	CbGeAlD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—nicotine dependence	0.000548	0.0104	CbGpPWpGaD
Naloxone—Vomiting—Varenicline—nicotine dependence	0.000546	0.0172	CcSEcCtD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000544	0.0103	CbGpPWpGaD
Naloxone—ABCB1—cardiovascular system—nicotine dependence	0.000538	0.023	CbGeAlD
Naloxone—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00053	0.01	CbGpPWpGaD
Naloxone—Nausea—Varenicline—nicotine dependence	0.00051	0.016	CcSEcCtD
Naloxone—CREB1—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000503	0.00951	CbGpPWpGaD
Naloxone—CREB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—nicotine dependence	0.000498	0.00942	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—GABRA4—nicotine dependence	0.000494	0.00934	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—CHRNB4—nicotine dependence	0.000473	0.00895	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000468	0.00885	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000465	0.0088	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000457	0.00864	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—CHRNA5—nicotine dependence	0.00044	0.00832	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000438	0.00828	CbGpPWpGaD
Naloxone—ABCB1—midbrain—nicotine dependence	0.00042	0.018	CbGeAlD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000412	0.0078	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000411	0.00776	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000393	0.00743	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000384	0.00726	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000374	0.00708	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000369	0.00699	CbGpPWpGaD
Naloxone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00036	0.00682	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—CHRNA3—nicotine dependence	0.000359	0.00678	CbGpPWpGaD
Naloxone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000356	0.00673	CbGpPWpGaD
Naloxone—TLR4—Immune System—WASF2—nicotine dependence	0.000349	0.0066	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000343	0.00648	CbGpPWpGaD
Naloxone—TLR4—Immune System—WASF1—nicotine dependence	0.000335	0.00633	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000324	0.00613	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—CHRNB2—nicotine dependence	0.000316	0.00597	CbGpPWpGaD
Naloxone—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000307	0.0058	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—DRD2—nicotine dependence	0.000304	0.00574	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000301	0.00568	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0003	0.00567	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000294	0.00555	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000292	0.00553	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000289	0.00547	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—CHRNA4—nicotine dependence	0.000287	0.00542	CbGpPWpGaD
Naloxone—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000285	0.00539	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000273	0.00516	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000272	0.00515	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000267	0.00505	CbGpPWpGaD
Naloxone—ABCB1—brain—nicotine dependence	0.000264	0.0113	CbGeAlD
Naloxone—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000263	0.00497	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000257	0.00487	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000248	0.00469	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000239	0.00451	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000235	0.00445	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000234	0.00443	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000224	0.00423	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000222	0.0042	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000217	0.00411	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000215	0.00406	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—FGD1—nicotine dependence	0.000214	0.00405	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000214	0.00404	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000212	0.00402	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—WASF2—nicotine dependence	0.000209	0.00396	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000206	0.0039	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000202	0.00382	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—WASF1—nicotine dependence	0.000201	0.00379	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000198	0.00374	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000196	0.00371	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000187	0.00354	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000186	0.00352	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000184	0.00347	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000174	0.0033	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000165	0.00311	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—CCAR1—nicotine dependence	0.000163	0.00307	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000162	0.00306	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000161	0.00305	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000161	0.00304	CbGpPWpGaD
Naloxone—CREB1—Disease—AKR1B10—nicotine dependence	0.00016	0.00302	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000158	0.00299	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000157	0.00298	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000155	0.00294	CbGpPWpGaD
Naloxone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000153	0.0029	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000142	0.00268	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000141	0.00267	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—FGD1—nicotine dependence	0.000127	0.00239	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000126	0.00239	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—FGD1—nicotine dependence	0.000126	0.00239	CbGpPWpGaD
Naloxone—CREB1—Immune System—WASF2—nicotine dependence	0.000122	0.0023	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	0.00012	0.00227	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000119	0.00225	CbGpPWpGaD
Naloxone—CREB1—Immune System—WASF1—nicotine dependence	0.000117	0.00221	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—OPRM1—nicotine dependence	0.000115	0.00218	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000115	0.00217	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKR1B10—nicotine dependence	0.000112	0.00211	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	0.000111	0.00211	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000111	0.0021	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—FGD1—nicotine dependence	0.000111	0.00209	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.002	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000105	0.00199	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000101	0.0019	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	0.000101	0.0019	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	9.77e-05	0.00185	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—FGD1—nicotine dependence	9.35e-05	0.00177	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	9.2e-05	0.00174	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	9.14e-05	0.00173	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—DRD2—nicotine dependence	8.32e-05	0.00157	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	8.3e-05	0.00157	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—FGD1—nicotine dependence	8.29e-05	0.00157	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	8.26e-05	0.00156	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	8.01e-05	0.00152	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—WASF2—nicotine dependence	7.88e-05	0.00149	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—WASF2—nicotine dependence	7.85e-05	0.00149	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—WASF1—nicotine dependence	7.55e-05	0.00143	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—WASF1—nicotine dependence	7.53e-05	0.00142	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKR1B10—nicotine dependence	7.32e-05	0.00139	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	7.28e-05	0.00138	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—WASF2—nicotine dependence	6.89e-05	0.0013	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—OPRM1—nicotine dependence	6.8e-05	0.00129	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	6.78e-05	0.00128	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	6.77e-05	0.00128	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—WASF1—nicotine dependence	6.6e-05	0.00125	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	6.15e-05	0.00116	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	5.94e-05	0.00112	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WASF2—nicotine dependence	5.82e-05	0.0011	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—WASF1—nicotine dependence	5.58e-05	0.00106	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WASF2—nicotine dependence	5.16e-05	0.000976	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—WASF1—nicotine dependence	4.95e-05	0.000936	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP2A7—nicotine dependence	4.95e-05	0.000935	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP2A7—nicotine dependence	4.92e-05	0.00093	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—DRD2—nicotine dependence	4.92e-05	0.00093	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—DRD2—nicotine dependence	4.9e-05	0.000927	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—OPRM1—nicotine dependence	4.45e-05	0.000842	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP2A7—nicotine dependence	4.31e-05	0.000815	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—DRD2—nicotine dependence	4.3e-05	0.000813	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—DRD2—nicotine dependence	3.63e-05	0.000687	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—DRD2—nicotine dependence	3.22e-05	0.000609	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.65e-05	0.000502	CbGpPWpGaD
